Who Paid My Doc
Surpass Evolve
Device Flow Diverter
PDI 07613327375152
General payments
$6,781,106
Research payments
$3,747,987
Through program year 2025, $6,781,106 in general payments and $3,747,987 in research payments were reported against Surpass Evolve (Flow Diverter).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,363,506 | 2,628 |
| 2025 | Research | $532,014 | 97 |
| 2024 | General | $948,658 | 1,938 |
| 2024 | Research | $1,074,239 | 133 |
| 2023 | General | $1,385,942 | 1,772 |
| 2023 | Research | $772,376 | 94 |
| 2022 | General | $1,442,766 | 2,059 |
| 2022 | Research | $764,055 | 113 |
| 2021 | General | $1,640,233 | 2,295 |
| 2021 | Research | $605,303 | 104 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,692 general · 541 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.